Combining the latest targeted biologic agents with the most advanced radiation
technologies has been an exciting development in the treatment of cancer patients …

As stereotactic body radiation therapy (SBRT) for gastrointestinal (GI) gains popularity, there
is a need to optimize doses and fractionation to minimize GI toxicity. GI organs that have …

Purpose Gastrointestinal injury occurs rarely with agents that affect the vascular endothelial
growth factor receptor and with abdominal stereotactic body radiation therapy (SBRT). We …

Approximately half of all patients with cancer receive radiotherapy, which is conventionally
delivered in relatively small doses (1.8–2 Gy) per daily fraction over one to two months …

Inconsistencies permeate the literature regarding small bowel dose tolerance limits for
stereotactic body radiation therapy (SBRT) treatments. In this review, we organized these …

Stereotactic body radiation therapy (SBRT) is generally a tumor-ablative radiation modality
using essential technologies capable of accurately and precisely damaging the target with a …

Stereotactic body radiotherapy (SBRT) is an emerging treatment for pancreas cancer and
liver tumors. Early data suggest excellent control rates for locally advanced pancreas …

PURPOSE: To identify the predictors for the development of severe gastroduodenal toxicity
(GDT) in patients treated with stereotactic body radiotherapy (SBRT) using 3 fractionations …

Recent advances allow safe and effective delivery of ablative doses of radiation with
stereotactic precision to tumours, resulting in very high levels of tumour control. Parallel …

Purpose To review the radiobiological mechanisms of stereotactic body radiation therapy
stereotactic body radiation therapy (SBRT) and stereotactic radiation surgery (SRS) …